Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This represents a minor site-version update and does not alter the study details, eligibility criteria, or user interactions.
    Difference
    0.1%
    Check dated 2026-01-14T03:37:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Updated the study's Locations information: a new Locations section is added and lists Kentucky, Minnesota, Missouri, and Nebraska. The previously separate state location entries (Kentucky Locations, Minnesota Locations, Missouri Locations, Nebraska Locations) have been removed in the new revision (v3.3.3).
    Difference
    0.5%
    Check dated 2025-12-23T22:05:24.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.2.0 to v3.3.2; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:31:33.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Removed the notice about potential disruptions due to a lapse in government funding; the ClinicalTrials.gov page content and study details remain intact. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:22:44.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Sponsor attribution (Alliance Foundation Trials, LLC.) and related headers were removed from the Study Details page, and a General Poster Session entry was deleted.
    Difference
    0.2%
    Check dated 2025-11-11T03:04:27.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Changes appear limited to formatting and visual layout with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:25:06.000Z thumbnail image

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.